Gilead rises after report that AstraZeneca has made merger approach Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Gilead (GILD) up 4% after Bloomberg reported AstraZeneca (AZN) has made a preliminary approach toward the company about a potential merger
- PG&E (PCG) up 3% after announcing that it currently expects to pursue $5.75B of underwritten public offerings of common stock and equity units as part of its plan to fund its emergence from Chapter 11
- Magenta Therapeutics (MGTA) up 5% after Goldman Sachs analyst Paul Choi upgraded shares to Buy from Neutral with an unchanged price target of $15
- Fiat Chrysler (FCAU) up 3% after
Reuters reported EU antitrust regulators could require concessions to approve its $50B merger with PSA (PUGOY)
UP AFTER EARNINGS -
- Thor Industries (THO) up 8%
- REV Group (REVG) up 11%
LOWER -
- AstraZeneca down 2% after the company was said to have made made a preliminary approach to rival drugmaker Gilead about a potential merger
- Yatra (YTRA) down 15% after Ebix announced it is considering a countersuit against the company following its merger deal termination
- Kezar Life Sciences (KZR) down 3% after filing to sell an undisclosed amount of common stock
Symbols:
GILD MGTA FCAU THO REVG AZN PCG YTRA KZR Keywords: Fly Intel, Wall Street, Top Stories, Stocks